Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18420-18426
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18420
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18420
Table 1 Patients’ demographic and clinical characteristics
Variable | Group A (n = 46) | Group B (n = 33) | P value |
Sex | |||
Male | 29 | 16 | 0.197 |
Female | 17 | 17 | |
Age (yr) | 54.67 ± 10.52 | 52.55 ± 9.76 | 0.364 |
Etiology | |||
HBV cirrhosis | 23 | 21 | 0.229 |
HCV cirrhosis | 3 | 3 | 1.000 |
Schistosoma cirrhosis | 6 | 1 | 0.253 |
Alcoholic cirrhosis | 3 | 0 | 0.369 |
Autoimmunity liver cirrhosis | 9 | 5 | 0.612 |
Cryptogenic | 2 | 3 | 0.700 |
Child-Pugh classification | 0.479 | ||
A | 30 | 24 | |
B | 16 | 9 | |
Longitudinal diameter of spleen (cm) | 18.03 ± 2.97 | 19.16 ± 2.95 | 0.101 |
Spleen volume index (cm3) | 1599.88 ± 791.84 | 1763.89 ± 715.56 | 0.348 |
Table 2 Intraoperative and postoperative data
Variable | Group A (n = 46) | Group B (n = 33) | P value |
Operative time (min) | 220.98 ± 56.92 | 208.79 ± 54.24 | 0.341 |
Estimated blood loss (mL) | 179.35 ± 157.96 | 158.18 ± 220.35 | 0.620 |
Volume of blood transfusion (n) | 2 | 0 | 0.626 |
VAS score of the first day | 2.50 ± 0.84 | 2.73 ± 0.91 | 0.255 |
First oral intake time after operation (d) | 1.46 ± 0.62 | 1.33 ± 0.60 | 0.380 |
Initial passage of flatus time (d) | 2.43 ± 0.91 | 2.58 ± 0.90 | 0.498 |
Postoperative off-bed activity time (d) | 2.57 ± 0.69 | 2.39 ± 0.66 | 0.270 |
Postoperative hospital stay (d) | 10.72 ± 2.62 | 11.30 ± 2.32 | 0.308 |
Perioperative complications | 6 | 4 | 1.000 |
Asymptomatic portal vein thrombosis | 5 | 3 | 1.000 |
Pancreatic fistula | 1 | 1 | 1.000 |
Incision complications | 0 | 0 | |
Pneumonia | 0 | 0 | |
Abdominal infection | 0 | 0 | |
Emergency operation for bleeding | 0 | 0 |
Table 3 Inflammatory response data
Variable | Group A (n = 46) | Group B (n = 33) | P value |
Postoperative subfebrile (T > 38.0 °C) days | 3.67 ± 2.92 | 2.33 ± 2.91 | 0.047 |
No fever, n | 7 | 11 | 0.058 |
WBC day 0, 109/L | 3.03 ± 1.85 | 2.35 ± 1.39 | 0.082 |
WBC day 1, 109/L | 11.33 ± 3.50 | 10.97 ± 3.61 | 0.654 |
WBC day 3, 109/L | 11.25 ± 3.61 | 11.89 ± 4.09 | 0.464 |
WBC day 7, 109/L | 8.73 ± 2.56 | 9.33 ± 3.83 | 0.400 |
Table 4 Postoperative hepatic and renal function
Variable | Group A (n = 46) | Group B (n = 33) | P value |
ALT day 0, U/L | 30.98 ± 23.33 | 29.64 ± 15.21 | 0.773 |
ALT day 1, U/L | 37.52 ± 18.47 | 33.27 ± 15.80 | 0.228 |
ALT day 3, U/L | 29.78 ± 23.27 | 31.97 ± 40.12 | 0.761 |
ALT day 7, U/L | 20.67 ± 11.73 | 21.52 ± 13.59 | 0.769 |
Creatinine day 0, umol/L | 72.35 ± 17.63 | 71.33 ± 16.83 | 0.797 |
Creatinine day 1, umol/L | 75.58 ± 16.37 | 73.18 ± 23.00 | 0.589 |
Creatinine day 3, umol/L | 60.15 ± 16.25 | 60.97 ± 20.53 | 0.843 |
Creatinine day 7, umol/L | 61.19 ± 14.54 | 60.52 ± 16.03 | 0.846 |
- Citation: Jiang GQ, Bai DS, Chen P, Qian JJ, Jin SJ, Yao J, Wang XD. Modified laparoscopic splenectomy and azygoportal disconnection combined with cell salvage is feasible and might reduce the need for blood transfusion. World J Gastroenterol 2014; 20(48): 18420-18426
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18420.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18420